哮喘患儿血清中维生素D3水平对哮喘控制和肺功能的影响及其临床意义

doi:10.13481/j.1671-587x.20180522

吉林大学学报(医学版) ›› 2018, Vol. 44 ›› Issue (05): 1010-1013.doi: 10.13481/j.1671-587x.20180522

哮喘患儿血清中维生素D3水平对哮喘控制和肺功能的影响及其临床意义

安倍莹¹, 李亚男², 具杨花², 王莹莹², 程航²

1. 吉林大学第一医院检验科, 吉林长春 130021;
2. 吉林大学第一医院小儿呼吸一科, 吉林长春 130021

收稿日期:2018-03-07 出版日期:2018-09-28 发布日期:2018-11-20
通讯作者: 程航,主治医师(Tel:0431-88782721,E-mail:chenghang_jlu@126.com) E-mail:chenghang_jlu@126.com
作者简介:安倍莹(1979-),女,吉林省长春市人,主管技师,医学硕士,主要从事临床检验方面的研究。
基金资助:
国家自然科学基金面上项目资助课题（81770026）；吉林省科技厅自然科学基金面上项目资助课题（201801011157JC）

Effects of serum vitamin D3 level on asthma control and pulmonary function in children with asthma and their clinical significances

AN Beiying¹, LI Yanan², JU Yanghua², WANG Yingying², CHENG Hang²

1. Department of Clinical Laboratory, First Hospital, Jilin university, Changchun 130021, China;
2. Department of Pediatric Respiration, First Hospital, Jilin University, Changchun 130021, China

Received:2018-03-07 Online:2018-09-28 Published:2018-11-20

摘要/Abstract

摘要： 目的：探讨不同控制水平哮喘患儿血清中25羟维生素D3（简称维生素D3）水平的差异，分析哮喘患儿血清中维生素D3水平与肺功能指标的相关性，阐明维生素D3水平对哮喘控制和肺功能的影响。方法：选取64例6~14岁哮喘患儿作为哮喘组，根据哮喘控制水平情况再分为良好控制组、部分控制组和未控制组，同时选取同年龄段健康体检儿童作为对照组18人。收集研究对象的一般资料，应用罗氏电化学发光法检测2组研究对象血清中维生素D3水平；应用肺功能仪检测肺功能指标，包括用力肺活量（FVC）、第1秒最大呼气量（FEV1）、第1秒用力呼气容积占预计值的百分比（FEV1% pred）和第1秒最大呼气率（FEV1/FVC%）。采用Wilcoxon秩和检验分析哮喘组和对照组研究对象血清中维生素D3水平，应用Kruskal-Wallis检验分析不同控制水平组患儿维生素D3水平差异，采用Spearman相关分析法分析维生素D3水平与哮喘患儿肺功能指标的关系。结果：哮喘组患儿血清中维生素D3水平明显低于对照组（P<0.05）；哮喘良好控制组患儿血清中维生素D3水平高于未控制组（P<0.05），但部分控制组患儿血清中维生素D3水平与良好控制组和未控制组比较差异无统计学意义（P>0.05）；维生素D3缺乏患儿在未控制组比例明显高于良好控制组（P<0.05）。维生素D3水平与FEV1和FEV1/FVC%呈正相关关系（r=0.651，P<0.01；r=0.642，P<0.01）。结论：哮喘患儿血清中维生素D3水平影响哮喘控制水平和肺功能，在哮喘治疗过程中应高度重视维生素D3不足或缺乏，补充维生素D3有望成为哮喘辅助治疗的重要手段。

关键词: 支气管哮喘, 维生素D3, 哮喘控制, 肺功能

Abstract: Objective:To explore the differences in the levels of 25 hydroxy vitamin D3(vitamin D3) of the asthmatic children with different control levels, to analyze the relationships between the vitamin D3 level and the pulmonary function indexes, and to clarify the effects of vitamin D3 level on the asthma control and the pulmonary function. Methods:A total of 64 asthmatic patients who aged from 6 to 14 years old were selected as asttma group, and then according to the control level, asthma groups were divided into well-controlled group, partially controlled group and uncontrolled group.Eighteen healthy children who aged from 6 to 14 years old were selected as control group.The general materials of subjects in gwo groups were collected. The levels of serum vitamin D3 of the subjects in two groups were detected by Roche electrochemiluminescence, and the pulmonary function indexes(FEV1,FEV1% pred, FEV1/FVC%, and FVC)were measured by spirometry. The levels serum of vitamin D3 of the subjects in asthma and control groups were analyzed by Wilcoxon rank sum test, the differences of vitamin D3 levels among different control level groups were analyzed by Kruskal-Wallis test, and the relationships between the vitamin D3 level and the pulmonary function indexes were analyzed by Spearman correlation analysis. Results:The serum vitamin D3 level of the children in asthma group was significantly lower than that in control group (P<0.05). The level of serum vitamin D3 of the children in well-controlled group was higher than that in uncontrolled group (P<0.05), but the level of serum vitamin D3 of the children in partially controlled group had no differences neither with well-controlled group nor with uncontrolled group (P>0.05). The percentage of children with vitamin D3 deficiency in uncontrolled group was significantly higher than that in well-controlled group (P<0.05). The vitamin D3 level was positively correlated with FEV1 and FEV1/FVC%(r=0.651,P<0.01;r=0.642,P<0.01). Conclusion:The level of serum vitamin D3 of the asthmatic children affects the control level of asthma and pulmonary function, so vitamin D3 inefficiency or deficiency should be paid attention in the treatment of asthma. Vitamin D3 supplementation is expected to be an important means of adjuvant treatment for asthma.

Key words: bronchial asthma, vitamin D3, asthma control, pulmonary function

中图分类号:

R562.25

安倍莹, 李亚男, 具杨花, 王莹莹, 程航. 哮喘患儿血清中维生素D3水平对哮喘控制和肺功能的影响及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(05): 1010-1013.

AN Beiying, LI Yanan, JU Yanghua, WANG Yingying, CHENG Hang. Effects of serum vitamin D3 level on asthma control and pulmonary function in children with asthma and their clinical significances[J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1010-1013.

参考文献

[1] 中华医学会儿科学分会呼吸学组. 儿童支气管哮喘诊断与防治指南(2016年版)[J]. 中华儿科杂志, 2016, 54(3):167-181.
[2] Raedler D,Schaub B. Immune mechanisms and development of childhood asthma[J].Lancet Respir Med, 2014, 2(8):647-656.
[3] Adams JS, Hewison M. Unexpected actions of vitamin D:new perspectives on the regulation of innate and adaptive immunity[J]. Nat Clinl Pract Endocrinol Metab, 2008, 4(2):80-82.
[4] Xystrakis E, Urry Z, Hawrylowicz CM. Regulatory T cell therapy as individualized medicine for asthma and allergy[J]. Curr Opin Allergy Clin Immunol, 2007, 7(6):535.
[5] Halim TY, Krauss RH, Sun AC, et al. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation[J]. Immunity, 2012, 36(3):451-463.
[6] 郝晓飞. 儿童哮喘急性发作期血清25-羟基维生素D、总IgE水平变化及临床意义[J]. 国际医药卫生导报, 2017, 23(2):169-172.
[7] 吕晓春, 刘向玲. 哮喘儿童血清1,25-二羟维生素D3表达水平变化及其意义[J]. 实用临床医药杂志, 2016, 20(24):66-68.
[8] Licona-Limón P, Kim LK, Palm NW, et al. TH2, allergy and group 2 innate lymphoid cells[J]. Nat Immunol, 2013, 14(6):536-542.
[9] Holick MF. Vitamin D deficiency[J]. Ned Tijdschr Geneeskd, 2007, 150(23):1315-1316.
[10] Shahin MYA, El-Lawah AA, Amin A, et al. Study of serum vitamin D level in adult patients with bronchial asthma[J]. Egypt Chest Dis Tubercul, 2017, 66(1):5-9.
[11] Brehm JM,Schuemann B,Fuhlbrigge AL,et al.Serum vitamin D levels and severe asthma exacerbations in the childhood asthma management Program Study[J]. J Allergy Clin Immunol, 2010, 126(1):52-58.
[12] 陈志, 邹庆. 25-羟基维生素D水平与儿童支气管哮喘发病的相关性分析[J]. 中国妇幼保健, 2017, 32(7):1474-1476.
[13] Baeke F, Takiishi T, Korf H, et al. Vitamin D:modulator of the immune system[J]. Curr Opin Pharmacol, 2010, 10(4):482-496.
[14] 徐丹丹, 徐赫男, 苏洁, 等. 血清维生素D与哮喘患者病情控制程度及肺功能的关系[J]. 中国老年学, 2017, 37(10):2487-2489.
[15] Brehm JM, Acosta-Pérez E, Klei L, et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children[J]. Am J Respir Crit Care Med, 2012, 186(2):140-142.
[16] Majak P, Olszowiec-Chlebna M, Smejda K, et al. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection[J]. J Allergy Clin Immunol, 2011, 127(5):1294-1296.
[17] Yadav M, Mittal K. Effect of vitamin D supplementation on moderate to severe bronchial asthma[J]. Indian J Pediatr, 2014, 81(7):650-654.
[18] 陈江, 任翼, 何娜, 等. 维生素D3的补充对儿童哮喘控制的随机对照研究[J]. 重庆医学, 2017, 46(32):4505-4507,4510.
[19] Burns JS, Dockery DW, Neas LM, et al. Low dietary nutrient intakes and respiratory health in adolescents[J]. Chest, 2007, 132(1):238-245.
[20] 郭巍, 赵春明, 赵岩峰. 血清25羟基维生素D与哮喘相关性研究[J]. 标记免疫分析与临床, 2016, 23(12):1430-1432.
[21] 段效军, 陈艳萍. 3岁以下哮喘患儿血清维生素D水平及其与肺功能的关系[J]. 医学临床研究, 2012, 29(2):306-308.
[22] Mehta AA, Agrawal AD, Appanna V, et al. Vitamin D improves corticosteroid efficacy and attenuates its side-effects in an animal model of asthma[J]. Can J Physiol Pharmacol, 2015, 93(1):53-61.

哮喘患儿血清中维生素D3水平对哮喘控制和肺功能的影响及其临床意义

Effects of serum vitamin D3 level on asthma control and pulmonary function in children with asthma and their clinical significances

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	李星, 井弘宇, 陈立婷, 李丹, 钱东华. 慢性咳嗽患者血清中IL-17、IL-33水平和FeNO浓度检测及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(01): 126-130.
[2]	张雪阳, 马骥, 孟广平, 王琦, 李伟, 徐艳玲, 张捷, 高鹏. 基于吉林省长春市区居民肺功能筛查的慢性阻塞性肺疾病患病现况调查分析[J]. 吉林大学学报(医学版), 2017, 43(05): 1047-1052.
[3]	陈丽燕, 唐颖, 张俐, 斯琴, 许力军. 支气管哮喘患者外周血中白细胞介素22水平的检测及其临床意义[J]. 吉林大学学报(医学版), 2017, 43(02): 349-352.
[4]	李艳凤, 王洪波, 高阳, 郑雨轩, 刘丽. 支气管哮喘患儿血清骨膜蛋白水平变化及其意义[J]. 吉林大学学报(医学版), 2017, 43(01): 101-105.
[5]	赵大辉, 张鹏, 汪建国, 王峰, 曹璐, 李玉香. 先天性脊柱侧弯与特发性脊柱侧弯对肺功能影响的对比分析[J]. 吉林大学学报(医学版), 2016, 42(02): 326-330.
[6]	李新，张舒岩，杨立彬，李冉，蒋然然，陈治光，李树蕾，李树红. Raw264.7细胞向破骨细胞分化诱导培养体系的改良[J]. 吉林大学学报(医学版), 2014, 40(05): 1114-1118.
[7]	陈敏，赖天文，招轩娜，吕莹莹，高拯妮，黄丹，刘升明. CHI3L1基因多态性和血清YKL-40水平与支气管哮喘发病的关联性[J]. 吉林大学学报(医学版), 2014, 40(05): 1058-1063.
[8]	徐晓光，姜振宇，杜敏娟，杨亚琴，蒋颖超. 沙美特罗/丙酸氟替卡松联合N-乙酰半胱氨酸治疗慢性阻塞性肺疾病的疗效评价[J]. 吉林大学学报(医学版), 2014, 40(04): 870-874.
[9]	孙博文，唐颖，李晓丹，许力军. 支气管哮喘患者外周血中IL-33水平的检测及其在支气管哮喘发病机制中的作用[J]. 吉林大学学报(医学版), 2014, 40(02): 395-398.
[10]	郭晓雪，马丽伟，李晓宁，刘颖，孙璐瑶，张连莲，于振香. 乙酰半胱氨酸联合异丙托溴铵对控制大鼠慢性阻塞性肺疾病病程进展的作用[J]. 吉林大学学报(医学版), 2013, 39(4): 694-698.
[11]	张力文，张云峰，尤海龙，刘丽，尹嘉宁. 长期舌下含服粉尘螨滴剂治疗儿童支气管哮喘的有效性和安全性评价[J]. 吉林大学学报(医学版), 2013, 39(1): 148-151.
[12]	王秀华\|刘丽\|乔红梅\|李亚男\|卢清华\|成焕吉. 特应性和非特应性哮喘患儿血清白细胞介素-10和血浆内皮素-1表达水平的检测及其临床意义[J]. J4, 2012, 38(3): 547-550.
[13]	唐颖\|丛中凰\|李晓丹\|许力军. 布地奈德/福莫特罗粉吸入治疗对支气管哮喘患者肺功能改善作用及血清细胞因子的影响[J]. J4, 2012, 38(1): 131-134.
[14]	李晓丹\|许力军\|刘超英\|邹奇\|丛中凰\|王满\|张洪泉. 联合雾化吸入治疗急性发作期支气管哮喘患者的效果评价[J]. J4, 2011, 37(6): 1120-1123.
[15]	张雨\|韦倩\|伊鹏霏. 黄芪对支气管哮喘大鼠支气管肺泡灌洗液及血清中NO、IL-5和炎症细胞的影响[J]. J4, 2011, 37(6): 1033-1036.